- All
- Product Management
- News
- Introduction
- Enterprise outlets
- FAQ
- Enterprise Video
- Enterprise Atlas
A picture to understand the 2019 half-year report of Livzon Pharmaceutical Group
Release time:
2019-08-17
In the first half of 2019, Livzon's operating income was 4.939 billion yuan, a year-on-year increase of 8.20%; net profit was 835 million yuan, a year-on-year increase of 23.50%; net profit attributable to the parent company was 739 million yuan, a year-on-year increase of 16.67%; net profit attributable to the parent company after deducting non-recurring gains and losses was 659 million yuan, a year-on-year increase of 15.32%.


Related Information
Address: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home